Trial intelligence / Profile preview

Buprenorphine/Naloxone Abuse Liability in Heroin Dependence

NCT00000330Phase 2Withdrawn

Sponsor
University of Colorado Denver
Start
Oct 1999
Primary completion
Nov 1999
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of buprenorphine, naloxone in heroin dependence, sponsored by University of Colorado Denver. Planned start Oct 1999; status: withdrawn.

02

Drugs

buprenorphinenaloxone
03

Conditions

heroin dependence

Beyond the preview

Go deeper on NCT00000330.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00000330.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call